| Feb 26, 2015 |
BOSTON, Feb. 26, 2015 (GLOBE NEWSWIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP) today announced financial results for the fourth quarter and full year ended December 31, 2014, and provided an update on the company's recent activities.
"ZIOPHARM has achieved remarkable progress in the last several quarters, uniting a number of technologies and d...
|
|
| Feb 12, 2015 |
BOSTON, Feb. 12, 2015 (GLOBE NEWSWIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP) today announced that the underwriters for its recently announced underwritten public offering of common stock have exercised in full their option to purchase an additional 1,500,000 shares of common stock at a public offering price of $8.75 per share. Gross proceeds to ...
|
|
| Feb 5, 2015 |
BOSTON, Feb. 5, 2015 (GLOBE NEWSWIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP), today announced that Jonathan Lewis, M.D., Ph.D., Chief Executive Officer, will present at the 17th Annual BIO CEO & Investor Conference on Tuesday, February 10th, 2015 at 10:30 a.m. ET. The conference is being held at the Waldorf Astoria Hotel in New York City.
To ...
|
|
| Feb 3, 2015 |
BOSTON, Feb. 3, 2015 (GLOBE NEWSWIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP) today announced that it has priced its previously announced underwritten public offering of common stock consisting of 10,000,000 shares at a public offering price of $8.75 per share. Gross proceeds to ZIOPHARM from this offering are expected to be approximately $87.5 mi...
|
|
| Feb 2, 2015 |
BOSTON, Feb. 2, 2015 (GLOBE NEWSWIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP) today announced that it intends to commence an underwritten public offering of $75,000,000 of shares of its common stock. All of the shares in the proposed offering are to be sold by ZIOPHARM.
J.P. Morgan Securities LLC is acting as sole book-running manager for the ...
|
|
| Jan 13, 2015 |
|
|
| Jan 7, 2015 |
BOSTON, Jan. 7, 2015 (GLOBE NEWSWIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP), today announced that Jonathan Lewis, M.D., Ph.D., Chief Executive Officer, will present at the 33rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 14th, 2015 at 3:30 p.m. PT at The Westin St. Francis in San Francisco, CA.
To access a live audio webca...
|
|
| Dec 3, 2014 |
BOSTON, Mass. and GERMANTOWN, Md., Dec. 3, 2014 (GLOBE NEWSWIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP), a biopharmaceutical company focused on the development and commercialization of new cancer therapies, and Intrexon Corporation (NYSE:XON), a leader in synthetic biology, today announced the presentation of clinical and preclinical studies from...
|
|
| Oct 30, 2014 |
BOSTON, Oct. 30, 2014 (GLOBE NEWSWIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP) today announced financial results for the third quarter ended September 30, 2014, and provided an update on the company's product development activities.
"During the third quarter, we continued to execute our strategy and advance our immuno-oncology platform, includ...
|
|
| Aug 7, 2014 |
BOSTON, Aug. 7, 2014 (GLOBE NEWSWIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP) today announced financial results for the second quarter ended June 30, 2014, and provided an update on the company's product development activities.
"ZIOPHARM, together with our channel partner Intrexon Corporation, continues to advance a portfolio of immuno-onc...
|
|
